MALT lymphoma: epidemiology, clinical diagnosis and treatment.
| Autor: | Violeta Filip P; 'Carol Davila' University of Medicine and Pharmacy, Bucharest.; Department of Internal Medicine II and Gastroenterology, Emergency University Hospital, Bucharest., Cuciureanu D; 'Carol Davila' University of Medicine and Pharmacy, Bucharest., Sorina Diaconu L; 'Carol Davila' University of Medicine and Pharmacy, Bucharest.; Department of Internal Medicine II and Gastroenterology, Emergency University Hospital, Bucharest., Maria Vladareanu A; 'Carol Davila' University of Medicine and Pharmacy, Bucharest.; Department of Internal Medicine II and Gastroenterology, Emergency University Hospital, Bucharest., Silvia Pop C; 'Carol Davila' University of Medicine and Pharmacy, Bucharest. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of medicine and life [J Med Life] 2018 Jul-Sep; Vol. 11 (3), pp. 187-193. |
| DOI: | 10.25122/jml-2018-0035 |
| Abstrakt: | Primary gastric lymphoma (PGL) represents a rare pathology, which can be easily misdiagnosed because of unspecific symptoms of the digestive tract. Histologically, PGL can vary from indolent marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) to aggressive diffuse large B-cell lymphoma (DLBCL). During the years, clinical trials revealed the important role of Helicobacter pylori (H. pylori) in the pathogenesis of gastric MALT lymphoma. Infection with Helicobacter pylori is an influential promoter of gastric lymphomagenesis initiation. Long-term studies revealed that eradication therapy could regress gastric lymphomas. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|